Fuenfstueck, R <br/><br/>
Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.  [electronic resource] 

 -  Advances in therapy   
 - 263-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0741-238X 
<br/><br/><label>Standard No.: </label>10.1007/BF02849935  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Antihypertensive Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Benzoates--administration & dosage<br/>Biphenyl Compounds<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Female<br/>Humans<br/>Hydrochlorothiazide--administration & dosage<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Telmisartan<br/>Tetrazoles--administration & dosage<br/>Valine--administration & dosage<br/>Valsartan